Welcome to LookChem.com Sign In|Join Free
  • or
1-methyl-4-[(2E)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]piperazine is a complex organic compound with a molecular formula of C20H26N2O5. It is a derivative of piperazine, a heterocyclic amine, and features a methyl group at the 1-position and a substituted propenoyl group at the 4-position. The propenoyl group is characterized by a 2E configuration, indicating the presence of a trans double bond, and is attached to a 3,4,5-trimethoxyphenyl ring. This chemical structure is significant in the field of medicinal chemistry, as it may exhibit biological activity or be used as a precursor in the synthesis of pharmaceuticals. The compound's properties, such as solubility and reactivity, are influenced by its molecular structure, making it a subject of interest for further research and potential applications in drug development.

1703-36-2

Post Buying Request

1703-36-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1703-36-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1703-36-2 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,7,0 and 3 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1703-36:
(6*1)+(5*7)+(4*0)+(3*3)+(2*3)+(1*6)=62
62 % 10 = 2
So 1703-36-2 is a valid CAS Registry Number.

1703-36-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name (E)-1-(4-methylpiperazin-1-yl)-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one

1.2 Other means of identification

Product number -
Other names Piperazine,1-methyl-4-(3,4,5-trimethoxycinnamoyl)

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1703-36-2 SDS

1703-36-2Downstream Products

1703-36-2Relevant academic research and scientific papers

Design, synthesis and biological evaluation of (E)-3-(3,4,5-trimethoxyphenyl) acrylic acid (TMCA) amide derivatives as anticonvulsant and sedative agents

Zhao, Zefeng,Bai, Yajun,Chen, Xufei,Wu, Shaoping,He, Xirui,Bai, Yujun,Sun, Ying,Zheng, Xiaohui

, p. 2387 - 2396 (2018/09/25)

In this article, a novel series of (E)-3-(3,4,5-trimethoxyphenyl)acrylic acid (TMCA) amide derivatives 1-18 were designed and synthesized by a facile and one-pot step, which were achieved with good yields using 1-hydroxybenzotriazole (HOBT) and 1-(3-Dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDCI) as activation system. All the synthesized derivatives were biologically evaluated for their anticonvulsant, sedative activity and neurotoxicity using the maximal electroshock (MES) model, sc-pentylenetetrazol (PTZ) model, pentobarbital sodium-induced sleeping model, and locomotor activity tests, respectively. Among them, compounds 4, 9 and 16 exhibited good anticonvulsant activity in primary evaluation. Furthermore, compound 4 is the most effective anticonvulsant and sedative agent in subsequent tests, while the low threshold of toxicity of compound 4 is vigilant. Compounds 9 and 16 also performed significantly anticonvulsant activity in subsequent tests with weak toxicity. The molecular modeling experiments also predicted good binding interactions of the obtained active molecules with the GABA transferas. Therefore, it could be concluded that the synthesized derivatives 4, 9 and 16 would represent useful lead compounds for further investigation in the development of anticonvulsant and sedative agents.

Synthesis and biological evaluation of new piplartine analogues as potent aldose reductase inhibitors (ARIs)

Rao, Vidadala Ramasubba,Muthenna, Puppala,Shankaraiah, Gundeti,Akileshwari, Chandrasekhar,Babu, Kothapalli Hari,Suresh, Ganji,Babu, Katragadda Suresh,Chandra Kumar, Rotte Sateesh,Prasad, Kothakonda Rajendra,Yadav, Potharaju Ashok,Petrash, J. Mark,Reddy, Geereddy Bhanuprakash,Rao, Janaswamy Madhusudana

, p. 344 - 361 (2013/01/15)

As a continuation of our efforts directed towards the development of anti-diabetic agents from natural sources, piplartine was isolated from Piper chaba, and was found to inhibit recombinant human ALR2 with an IC50 of 160 μM. To improve the efficacy, a series of analogues have been synthesized by modification of the styryl/aromatic and heterocyclic ring functionalities of this natural product lead. All the derivatives were tested for their ALR2 inhibitory activity, and results indicated that adducts 3c, 3e and 2j prepared by the Michael addition of piplartine with indole derivatives displayed potent ARI activity, while the other compounds displayed varying degrees of inhibition. The active compounds were also capable of preventing sorbitol accumulation in human red blood cells.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1703-36-2